Papers
2
Total Citations
31
H-Index
2
About
Kate Dinneen is a pioneering urologic surgeon and researcher whose work centers on improving surgical precision in prostate cancer treatment, specifically through intraoperative margin assessment. Her major contributions focus on advancing fluorescence confocal microscopy (FCM) for real-time detection of positive surgical margins during robot-assisted radical prostatectomy. Dinneen developed the innovative LaserSAFE technique, which enables high-resolution, digital microscopic evaluation of fresh surgical specimens, offering a faster, more accurate alternative to traditional frozen section analysis. Her landmark 2024 study, cited 19 times, validated the technique’s accuracy through blind assessment and inter-rater agreement analysis, demonstrating its potential to reduce residual cancer and improve patient outcomes. A 2023 paper, with 12 citations, further refined the methodology, establishing her as a leader in this niche. Dinneen’s work bridges surgical oncology and imaging technology, directly impacting clinical decision-making during prostate cancer surgery. Her achievements include pioneering a technique that could become a new standard of care, earning recognition among peers for its translational value. For students and researchers, Dinneen exemplifies how targeted innovation in surgical pathology can enhance oncologic precision and patient safety.
Research Focus
Key Achievements
Top Papers
- 1
- 2